AbstractThe main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community. View Full-Text
Share & Cite This Article
da Silva Santos, S.; Igne Ferreira, E.; Giarolla, J. Dendrimer Prodrugs. Molecules 2016, 21, 686.
da Silva Santos S, Igne Ferreira E, Giarolla J. Dendrimer Prodrugs. Molecules. 2016; 21(6):686.Chicago/Turabian Style
da Silva Santos, Soraya; Igne Ferreira, Elizabeth; Giarolla, Jeanine. 2016. "Dendrimer Prodrugs." Molecules 21, no. 6: 686.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.